Neogen Chemicals Limited Stock Current Valuation
| NEOGEN Stock | 1,922 19.15 0.99% |
Valuation analysis of Neogen Chemicals helps investors to measure Neogen Chemicals' intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. At present, Neogen Chemicals' Begin Period Cash Flow is projected to increase significantly based on the last few years of reporting. The current year's Other Non Cash Items is expected to grow to about 317.1 M, whereas Cash is forecasted to decline to about 67.9 M. Fundamental drivers impacting Neogen Chemicals' valuation include:
Price Book 6.5885 | Enterprise Value 55.4 B | Enterprise Value Ebitda 44.8688 | Price Sales 7.4802 | Trailing PE 130.7049 |
Fairly Valued
Today
Please note that Neogen Chemicals' price fluctuation is very steady at this time. Calculation of the real value of Neogen Chemicals is based on 3 months time horizon. Increasing Neogen Chemicals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Neogen Chemicals is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Neogen Stock. However, Neogen Chemicals' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1921.8 | Real 1913.31 | Hype 1928.55 |
The real value of Neogen Stock, also known as its intrinsic value, is the underlying worth of Neogen Chemicals Company, which is reflected in its stock price. It is based on Neogen Chemicals' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Neogen Chemicals' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Neogen Chemicals Limited helps investors to forecast how Neogen stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Neogen Chemicals more accurately as focusing exclusively on Neogen Chemicals' fundamentals will not take into account other important factors: Neogen Chemicals Limited Company Current Valuation Analysis
Neogen Chemicals' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Neogen Chemicals Current Valuation | 55.38 B |
Most of Neogen Chemicals' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Neogen Chemicals Limited is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Neogen Chemicals Limited has a Current Valuation of 55.38 B. This is 385.37% higher than that of the Chemicals sector and 79.75% higher than that of the Materials industry. The current valuation for all India stocks is significantly lower than that of the firm.
Neogen Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Neogen Chemicals' direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Neogen Chemicals could also be used in its relative valuation, which is a method of valuing Neogen Chemicals by comparing valuation metrics of similar companies.Neogen Chemicals is currently under evaluation in current valuation category among its peers.
Neogen Fundamentals
| Return On Equity | 0.0574 | ||||
| Return On Asset | 0.0433 | ||||
| Profit Margin | 0.05 % | ||||
| Operating Margin | 0.13 % | ||||
| Current Valuation | 55.38 B | ||||
| Shares Outstanding | 26.38 M | ||||
| Shares Owned By Insiders | 53.25 % | ||||
| Shares Owned By Institutions | 25.10 % | ||||
| Price To Book | 6.59 X | ||||
| Price To Sales | 7.48 X | ||||
| Revenue | 6.91 B | ||||
| Gross Profit | 2.12 B | ||||
| EBITDA | 1.13 B | ||||
| Net Income | 356.5 M | ||||
| Total Debt | 4.09 B | ||||
| Book Value Per Share | 288.19 X | ||||
| Cash Flow From Operations | (291.5 M) | ||||
| Earnings Per Share | 15.18 X | ||||
| Target Price | 2286.75 | ||||
| Number Of Employees | 588 | ||||
| Beta | 0.39 | ||||
| Market Capitalization | 52.79 B | ||||
| Total Asset | 14.61 B | ||||
| Retained Earnings | 1.98 B | ||||
| Working Capital | 2.57 B | ||||
| Annual Yield | 0 % | ||||
| Net Asset | 14.61 B |
About Neogen Chemicals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Neogen Chemicals Limited's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Neogen Chemicals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Neogen Chemicals Limited based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Neogen Stock
Neogen Chemicals financial ratios help investors to determine whether Neogen Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Neogen with respect to the benefits of owning Neogen Chemicals security.